Analyst consensus rating
Aura Biosciences Analyst Rating: Strong Buy
AURA is rated Strong Buy by 5 analysts with a $16.60 target. As of 2026-08-23.
Direct answer
Aura Biosciences's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.60.
Forecast evidence checked August 23, 2026.
Get free Aura Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.80
- Average price target
- $16.60
- High price target
- $23.00
- Low price target
- $12.00
- Low target gap
- +53.8%
- Target upside
- +112.8%
- High target gap
- +194.9%
- Target range width
- 141%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Aura Biosciences?
Aura Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $16.60.
How far are Aura Biosciences's low and high targets from the recorded price?
The low target implies +53.8%, while the high target implies +194.9%.
How many analysts are included in Aura Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Aura Biosciences's target upside or downside calculated?
The average target of $16.60 is divided by the recorded price of $7.80, then one is subtracted to produce +112.8%. This does not guarantee a future return.
When was Aura Biosciences's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.